Literature DB >> 31848495

[Clinical characteristics of psoriatic arthritis with positive rheumatoid factor or anti-cyclic citrullinated peptide antibody].

L Y Dai1, D D Gong2, J X Zhao1.   

Abstract

OBJECTIVE: To analyze the clinical and laboratory features of psoriatic arthritis (PsA) patients with positive rheumatoid factor (RF) or anti-cyclic citrullinated peptide (CCP) antibody.
METHODS: In the study, 77 PsA patients who were hospitalized in the Department of Rheumatology and Immunology of Peking University Third Hospital from January 2007 to June 2019 were enrolled. All the patients met Classification Criteria for Psoriatic Arthritis or Moll or Wright Criteria. Rheumatoid factor (RF) and anti-cyclic-citrullinated peptide (CCP) antibody were tested in these patients. According to whether anti-CCP antibody or RF was detected in serum, all the patients were divided into anti-CCP antibody or RF positive group (15 cases), anti-CCP antibody or RF negative group (62 cases). According to the detection of anti-CCP antibody in serum, all the patients were divided into anti-CCP antibody positive group (7 cases) and anti-CCP antibody negative group (70 cases). Clinical and laboratory data were collected. The differences of clinical and laboratory indicators between the RF or anti-CCP antibody positive and negative PsA patients were compared. Clinical and laboratory indicators between the anti-CCP antibody positive and negative patients were also compared.
RESULTS: Among the 77 patients, 15 were RF or anti-CCP antibody positive, of whom 8 were only RF positive and 2 were only anti-CCP antibody positive, and both of RF and anti-CCP antibody were positive in 5 cases. The RF or anti-CCP antibody positive PsA patients were older than those in the negative group [(58.2±14.8) years vs. (46.69±12.27) years, P=0.002]. And metacarpophalangeal joints, elbow joints and shoulder joints were more likely to be involved in RF or anti-CCP antibody positive PsA patients. PsA patients in the anti-CCP antibody positive group were older than those in the negative group [(62.43±14.34) years vs. (47.59±12.75) years old, P=0.005]. The positive rate of RF and serum level of fibrinogen in the anti-CCP antibody positive group were higher than those in the negative group. The PsA patients in the anti-CCP antibody positive group were all polyarthritis, while 68.6% patients in the negative group were polyarthritis, but there was no statistical difference between the two groups. There was no statistical difference in sausage fingers/toes, changes in nails and enthesitis, and bone erosion on radiographs between the RF or anti-CCP antibody positive and negative PsA patients. There was also no statistical difference in sausage fingers/toes, bone erosion on radiographs, and changes in nails and enthesitis between the anti-CCP antibody positive and negative patients.
CONCLUSION: RF and anti-CCP antibodies can be detected in the serum of some PsA patients. RF or anti-CCP antibody positive PsA patients were older than those in negative PsA patients. Metacarpophalangeal joints, elbow joints and shoulder joints were more likely to be involved in RF or anti-CCP antibody positive PsA patients. Anti-CCP antibody positive PsA patients were older and had higher levels of RF positive rate and fibrinogen level.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31848495      PMCID: PMC7433586     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  12 in total

1.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

Authors:  William Taylor; Dafna Gladman; Philip Helliwell; Antonio Marchesoni; Philip Mease; Herman Mielants
Journal:  Arthritis Rheum       Date:  2006-08

2.  Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.

Authors:  Hitoshi Kohsaka; Tsuneyo Mimori; Takashi Kanda; Jun Shimizu; Yoshihide Sunada; Manabu Fujimoto; Yasushi Kawaguchi; Masatoshi Jinnin; Yoshinao Muro; Shoichiro Ishihara; Hiroyuki Tomimitsu; Akiko Ohta; Takayuki Sumida
Journal:  Mod Rheumatol       Date:  2018-12-19       Impact factor: 3.023

Review 3.  Psoriatic Arthritis.

Authors:  Christopher T Ritchlin; Robert A Colbert; Dafna D Gladman
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

Review 4.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

5.  The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.

Authors:  Yeliz Özkaya Eker; Ömer Nuri Pamuk; Gülsüm Emel Pamuk; Salim Dönmez; Necati Çakır
Journal:  Eur J Rheumatol       Date:  2014-06-01

6.  The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.

Authors:  E Korendowych; P Owen; J Ravindran; C Carmichael; N McHugh
Journal:  Rheumatology (Oxford)       Date:  2005-05-18       Impact factor: 7.580

7.  Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.

Authors:  N Inanc; E Dalkilic; S Kamali; E Kasapoglu-Günal; Y Elbir; H Direskeneli; M Inanc
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

8.  Classification criteria of early rheumatoid arthritis and validation of its performance in a multi-centre cohort.

Authors:  Jinxia Zhao; Yin Su; Ru Li; Hua Ye; Qinghua Zou; Yongfei Fang; Huaxiang Liu; Xingfu Li; Jialong Guo; Liqi Bi; Fei Gu; Lingyun Sun; Yifang Mei; Zhiyi Zhang; Lina Chen; Ping Zhu; Guangtao Li; Zhuoli Zhang; Xiaomei Leng; Yan Zhao; Li Jiang; Hejian Zou; Yi Zhao; Yi Liu; Lei Li; Hongyuan Wang; Xiangyuan Liu; Zhanguo Li
Journal:  Clin Exp Rheumatol       Date:  2014-09-05       Impact factor: 4.473

Review 9.  Anti-cyclic citrullinated peptide antibodies in psoriatic arthritis--cross-sectional study and literature review.

Authors:  C Popescu; S Zofotă; V Bojincă; R Ionescu
Journal:  J Med Life       Date:  2013-12-25

10.  Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis.

Authors:  Frank Behrens; Michaela Koehm; Diamant Thaçi; Holger Gnann; Gerd Greger; Bianca Maria Wittig; Harald Burkhardt
Journal:  Rheumatology (Oxford)       Date:  2016-06-21       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.